title: Phospholipase A2 activity in serum is induced during treatment with recombinant human interleukin-6 in patients with cancer.
authors.affiliation: Institut für Klinische Chemie, Klinikum der Stadt Mannheim, Universität Heidelberg, Germany.
authors.forename: T
authors.initials: T
authors.lastname: Bertsch
authors.forename: R E
authors.initials: RE
authors.lastname: Banks
authors.forename: M A
authors.initials: MA
authors.lastname: Forbes
authors.forename: J
authors.initials: J
authors.lastname: Aufenanger
authors.forename: M
authors.initials: M
authors.lastname: Storr
authors.forename: J M
authors.initials: JM
authors.lastname: Illingworth
authors.forename: T J
authors.initials: TJ
authors.lastname: Perren
authors.forename: P J
authors.initials: PJ
authors.lastname: Selby
authors.forename: R
authors.initials: R
authors.lastname: Kattermann
mesh_terms: D000328:Adult; D000368:Aged; D005260:Female; D006801:Humans; D015850:Interleukin-6 / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D010741:Phospholipases A / Q000097:blood*; D054467:Phospholipases A2; D011994:Recombinant Proteins / Q000627:therapeutic use; D014409:Tumor Necrosis Factor-alpha / Q000032:analysis
chemical_list: D015850:Interleukin-6; D011994:Recombinant Proteins; D014409:Tumor Necrosis Factor-alpha; D010741:Phospholipases A; D054467:Phospholipases A2